Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials

Fabrice André, Nadia Solovieff, Fei Su, Aditya Bardia, Patrick Neven, Yoon Sim Yap, Debu Tripathy, Yen‐Shen Lu, DJ Slamon, Stephen Chia, Molishree Joshi, A. Chakravartty, Aida Lteif, T Taran, Carlos L. Arteaga